TDC
STJ

Thompson Davis & Co’s St Jude Medical STJ Stock Holding History

Thompson Davis & Co’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-82
Closed -$6K – 1237
2016
Q2 		$6K Sell
82
-192
-70% -$13.7K 0.01% 768
2016
Q1 		$15K Buy
274
+86
+46% +$4.69K 0.02% 548
2015
Q4 		$12K Sell
188
-128
-41% -$8.07K 0.02% 627
2015
Q3 		$20K Buy
316
+23
+8% +$1.64K 0.03% 473
2015
Q2 		$21K Sell
293
-25
-8% -$1.81K 0.02% 531
2015
Q1 		$21K Sell
318
-1,070
-77% -$71.1K 0.03% 524
2014
Q4 		$90K Buy
1,388
+85
+7% +$5.47K 0.1% 194
2014
Q3 		$78K Buy
+1,303
New +$85.1K 0.1% 201

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Thompson Davis & Co's STJ Position: Q3 2016 in Review

Thompson Davis & Co sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 82 shares — an estimated $6K sold.

Thompson Davis & Co first reported a position in STJ in Q3 2014 and held it in 8 quarters. The position peaked at $90K in Q4 2014. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Thompson Davis & Co reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Thompson Davis & Co sold 82 St Jude Medical shares in Q3 2016, an estimated $6K.
  • Thompson Davis & Co first reported a position in St Jude Medical in Q3 2014 and held it in 8 quarters.
  • Thompson Davis & Co's St Jude Medical position peaked at $90K in Q4 2014.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Thompson Davis & Co's 13F filing for Q3 2016, filed 8 Nov 2016.